Page last updated: 2024-08-17

bromodeoxyuridine and cambinol

bromodeoxyuridine has been researched along with cambinol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Czerwonka, A; Luszczki, J; Okon, E; Telejko, I; Wawruszak, A	1

Other Studies

1 other study(ies) available for bromodeoxyuridine and cambinol

Article	Year
Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells. Pharmacological reports : PR, 2022, Volume: 74, Issue:5 Topics: Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Female; Histone Deacetylase Inhibitors; Humans; Paclitaxel; Sirtuins; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2022

Article

Year

Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells.

Pharmacological reports : PR, 2022, Volume: 74, Issue:5

Topics: Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Female; Histone Deacetylase Inhibitors; Humans; Paclitaxel; Sirtuins; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2022